Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Malar J ; 14: 326, 2015 Aug 21.
Article in English | MEDLINE | ID: mdl-26293655

ABSTRACT

BACKGROUND: Several platforms have been used to generate the primary data for microsatellite analysis of malaria parasite genotypes. Each has relative advantages but share a limitation of being time- and cost-intensive. A commercially available automated capillary gel cartridge system was assessed in the microsatellite analysis of Plasmodium vivax diversity in the Peruvian Amazon. METHODS: The reproducibility and accuracy of a commercially-available automated capillary system, QIAxcel, was assessed using a sequenced PCR product of 227 base pairs. This product was measured 42 times, then 27 P. vivax samples from Peruvian Amazon subjects were analyzed with this instrument using five informative microsatellites. Results from the QIAxcel system were compared with a Sanger-type sequencing machine, the ABI PRISM(®) 3100 Genetic Analyzer. RESULTS: Significant differences were seen between the sequenced amplicons and the results from the QIAxcel instrument. Different runs, plates and cartridges yielded significantly different results. Additionally, allele size decreased with each run by 0.045, or 1 bp, every three plates. QIAxcel and ABI PRISM systems differed in giving different values than those obtained by ABI PRISM, and too many (i.e. inaccurate) alleles per locus were also seen with the automated instrument. CONCLUSIONS: While P. vivax diversity could generally be estimated using an automated capillary gel cartridge system, the data demonstrate that this system is not sufficiently precise for reliably identifying parasite strains via microsatellite analysis. This conclusion reached after systematic analysis was due both to inadequate precision and poor reproducibility in measuring PCR product size.


Subject(s)
Malaria, Vivax/parasitology , Microsatellite Repeats/genetics , Molecular Typing/methods , Plasmodium vivax/genetics , DNA, Protozoan/genetics , Humans , Malaria, Vivax/epidemiology , Molecular Epidemiology , Peru/epidemiology , Reproducibility of Results
2.
PLoS Negl Trop Dis ; 4(5): e688, 2010 May 18.
Article in English | MEDLINE | ID: mdl-20502520

ABSTRACT

BACKGROUND: Patients with Chagas disease have migrated to cities, where obesity, hypertension and other cardiac risk factors are common. METHODOLOGY/PRINCIPAL FINDINGS: The study included adult patients evaluated by the cardiology service in a public hospital in Santa Cruz, Bolivia. Data included risk factors for T. cruzi infection, medical history, physical examination, electrocardiogram, echocardiogram, and contact 9 months after initial data collection to ascertain mortality. Serology and PCR for Trypanosoma cruzi were performed. Of 394 participants, 251 (64%) had confirmed T. cruzi infection by serology. Among seropositive participants, 109 (43%) had positive results by conventional PCR; of these, 89 (82%) also had positive results by real time PCR. There was a high prevalence of hypertension (64%) and overweight (body mass index [BMI] >25; 67%), with no difference by T. cruzi infection status. Nearly 60% of symptomatic congestive heart failure was attributed to Chagas cardiomyopathy; mortality was also higher for seropositive than seronegative patients (p = 0.05). In multivariable models, longer residence in an endemic province, residence in a rural area and poor housing conditions were associated with T. cruzi infection. Male sex, increasing age and poor housing were independent predictors of Chagas cardiomyopathy severity. Males and participants with BMI

Subject(s)
Chagas Cardiomyopathy/epidemiology , Chagas Cardiomyopathy/pathology , Trypanosoma cruzi/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Antibodies, Protozoan/blood , Bolivia/epidemiology , Chagas Cardiomyopathy/complications , Chagas Cardiomyopathy/mortality , Chronic Disease , DNA, Protozoan/blood , Enzyme-Linked Immunosorbent Assay , Female , Heart Failure/epidemiology , Heart Failure/etiology , Humans , Male , Middle Aged , Polymerase Chain Reaction , Prevalence , Risk Factors , Trypanosoma cruzi/genetics , Trypanosoma cruzi/immunology , Young Adult
3.
Emerg Infect Dis ; 10(6): 1016-22, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15207052

ABSTRACT

Human infection by leptospires has highly variable clinical manifestations, which range from subclinical infection to fulminant disease. We conducted a population-based, cross-sectional seroepidemiologic study in Peru to determine potential relationships of environmental context to human exposure to Leptospira and disease associated with seroconversion. Three areas were studied: a flooded, urban slum in the Peruvian Amazon city of Iquitos; rural, peri-Iquitos villages; and a desert shantytown near Lima. Seroprevalence in Belen was 28% (182/650); in rural areas, 17% (52/316); and in a desert shantytown, 0.7% (1/150). Leptospira-infected peridomestic rats were found in all locales. In Belen, 20 (12.4%) of 161 patients seroconverted between dry and wet seasons (an incidence rate of 288/1,000). Seroconversion was associated with history of febrile illness; severe leptospirosis was not seen. Human exposure to Leptospira in the Iquitos region is high, likely related both to the ubiquity of leptospires in the environment and human behavior conducive to transmission from infected zoonotic sources.


Subject(s)
Environmental Exposure , Leptospira/isolation & purification , Leptospirosis/epidemiology , Rats/parasitology , Adolescent , Adult , Aged , Animals , Antibodies, Protozoan/blood , Child , Child, Preschool , DNA, Protozoan/chemistry , DNA, Protozoan/genetics , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant , Leptospira/genetics , Leptospirosis/parasitology , Leptospirosis/transmission , Male , Middle Aged , Peru/epidemiology , Polymerase Chain Reaction , Poverty , Seroepidemiologic Studies , Tropical Climate
SELECTION OF CITATIONS
SEARCH DETAIL